OTC-601: Being developed for Huntington’s disease.

Brief information about it:

OTC-601 is an investigational therapy being developed for the treatment of Huntington’s disease, a neurodegenerative disorder that causes progressive damage to brain cells.

 Uses:

Huntington’s disease: OTC-601 is designed to address the underlying genetic defect in Huntington’s disease, which leads to the production of a harmful protein called huntingtin.

 Mechanism of action:

OTC-601 is a small molecule compound that works by targeting the huntingtin protein and reducing its toxicity. This may help slow down the progression of Huntington’s disease and improve symptoms.

Elimination half life:

The elimination half-life of OTC-601 can vary depending on individual factors. It is generally excreted from the body within 24-48 hours.

Route of Administration:

OTC-601 is administered orally as a tablet or capsule.

 Side effects:

OTC-601 can cause side effects, including:

• Digestive issues: Nausea, vomiting, and diarrhea are common side effects.
• Headaches
• Fatigue
• Weight gain

 Dose:

The recommended dose of OTC-601 is determined based on individual factors, such as weight and overall health.

 Precautions:

·  Consult a doctor: Before taking OTC-601, consult with a healthcare professional to ensure it is safe for you and to discuss potential risks and benefits.

·  Medical history: Inform your doctor about any personal or family history of conditions such as liver or kidney disease.

·  Pregnancy and breastfeeding: If you are pregnant or breastfeeding, consult with your doctor before taking OTC-601.